Viatris Inc (NASDAQ:VTRS)
| 9.39 Delayed Data As of 4:00pm ET |  -0.135 / -1.42%Today’s Change | 8.42 Today|||52-Week Range 12.40 | -15.68% Year-to-Date |
Latest VTRS News | Press Releases
| These 2 Dividend Stocks Yield 5% -- and They Aren't Risky Buys Jun 08 / MotleyFool.com - Paid Partner Content | Looking for Passive Income at a Decent Price? Buy These 2 Stocks Jun 05 / MotleyFool.com - Paid Partner Content |
| Why Is Viatris (VTRS) Down 2.4% Since Last Earnings Report? Jun 07 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.52 |
| Today’s open | 9.48 |
| Day’s range | 9.35 - 9.48 |
| Volume | 253,632 |
| Average volume (3 months) | 9,438,675 |
| Market cap | $11.2B |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -12.12% |
| Earnings growth (next 5 years) | -1.16% |
| Revenue growth (last year) | -9.42% |
| P/E ratio | 6.0 |
| Price/Sales | 0.84 |
| Price/Book | 0.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRPTSarepta Therapeutics... | +1.79 | +1.42% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 7, 2023 |
| EPS forecast (this quarter) | $0.71 |
| Annual revenue (last year) | $16.2B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 12.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Canonsburg, Pennsylvania |
Forecasts
